Clinical Trials Browser

Phase 3 × Unknown × Ondansetron × Clear all

NCT05872893 2023-07-21

Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone

Phase 3 Unknown

Neoplasms

NCT02979548 2017-01-25

Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01536691 2012-10-03

ROAD

Phase 3 Unknown

Neoplasms, Vomiting